APO Research
Talk to an analyst

APO RESEARCH · REPORT

Medical Polymers

The medical polymers market comprises resins and fibers, elastomers and biodegradable plastics that are used in various healthcare applications such as equipment and devices, packaging and tissue engineering. Polyvinyl chloride, polypropylene, polystyrene and polyethylene are the commonly used fibers and resins in the medical industry.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

The medical polymers market comprises resins and fibers, elastomers and biodegradable plastics that are used in various healthcare applications such as equipment and devices, packaging and tissue engineering. Polyvinyl chloride, polypropylene, polystyrene and polyethylene are the commonly used fibers and resins in the medical industry.

Selected research

Market Outlook & Growth Opportunities

Global Medical Polymers Market Outlook and Growth Opportunities 2026

2 January 2026206 pages

Choose your research edition.

Industry ResearchMedical Polymers Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Medical Polymers Industry Growth and Trends Forecast to 2032115 pages · $3,450 USDMarket StructureGlobal Medical Polymers Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Medical Polymers Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal Medical Polymers Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The medical polymers market comprises resins and fibers, elastomers and biodegradable plastics that are used in various healthcare applications such as equipment and devices, packaging and tissue engineering. Polyvinyl chloride, polypropylene, polystyrene and polyethylene are the commonly used fibers and resins in the medical industry.

The major players in global Medical Polymers market include BASF SE, Bayer, Celanese, DSM, Du Pont, etc. The top 5 players occupy about 20% shares of the global market. Europe and North America are main markets, they occupy over 60% of the global market. Medical Resins and Fibers is the main type, with a share about 80%. Medical Packaging is the main application, which holds a share about 50%.

This report provides an overview of the global Medical Polymers market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Medical Polymers and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Medical Polymers sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Medical Polymers market size, projected growth trends, production technologies, key applications, and end-use industries.

Medical Polymers Segment by Company

BASF SE

Bayer

Celanese

DSM

DuPont

Solvay

Eastman Chemical

Evonik

HEXPOL

Exxon Mobil

Formosa Plastics

INEOS

Victrex

Colorite Compounds

Raumedic

Kraton

Tianjin Plastics

Shanghai New Shanghua

Medical Polymers Segment by Type

Medical Resins and Fibers

Medical Elastomers

Biodegradable Plastics

Other

Medical Polymers Segment by Application

Medical Devices and Equipment

Medical Packaging

Others (Including Tissue Engineering and Cardio Stents)

Medical Polymers Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Medical Polymers status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Medical Polymers market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Medical Polymers significant trends, drivers, influence factors in global and regions.

6. To analyze Medical Polymers competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Polymers market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Medical Polymers and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Polymers.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Medical Polymers market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Medical Polymers industry.

Chapter 3: Detailed analysis of Medical Polymers manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Medical Polymers in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Medical Polymers in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Medical Polymers Industry Trends Table 2. Medical Polymers Industry Drivers Table 3. Medical Polymers Industry Opportunities and Challenges Table 4. Medical Polymers Industry Restraints Table 5. Global Medical Polymers Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Medical Polymers Revenue Share by Company (2021-2026) Table 7. Global Medical Polymers Sales Volume by Company (kt) & (2021-2026) Table 8. Global Medical Polymers Sales Volume Share by Company (2021-2026) Table 9. Global Medical Polymers Average Price (US$/t) of Company (2021-2026) Table 10. Global Medical Polymers Company Ranking, (2024-2026) & (USD Million) Table 11. Global Medical Polymers Key Company Manufacturing Base & Headquarters Table 12. Global Medical Polymers Company, Product Type & Application Table 13. Global Medical Polymers Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Medical Polymers by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Medical Resins and Fibers Table 18. Significant Companies of Medical Elastomers Table 19. Significant Companies of Biodegradable Plastics Table 20. Significant Companies of Other Table 21. Global Medical Polymers Sales Volume by Type 2021 VS 2025 VS 2032 (kt) Table 22. Global Medical Polymers Sales Volume by Type (2021-2026) & (kt) Table 23. Global Medical Polymers Sales Volume by Type (2027-2032) & (kt) Table 24. Global Medical Polymers Sales Volume Share by Type (2021-2026) Table 25. Global Medical Polymers Sales Volume Share by Type (2027-2032) Table 26. Global Medical Polymers Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Medical Polymers Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Medical Polymers Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Medical Polymers Sales Value Share by Type (2021-2026) Table 30. Global Medical Polymers Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Medical Devices and Equipment Table 32. Significant Companies of Medical Packaging Table 33. Significant Companies of Others (Including Tissue Engineering and Cardio Stents) Table 34. Global Medical Polymers Sales Volume by Application 2021 VS 2025 VS 2032 (kt) Table 35. Global Medical Polymers Sales Volume by Application (2021-2026) & (kt) Table 36. Global Medical Polymers Sales Volume by Application (2027-2032) & (kt) Table 37. Global Medical Polymers Sales Volume Share by Application (2021-2026) Table 38. Global Medical Polymers Sales Volume Share by Application (2027-2032) Table 39. Global Medical Polymers Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Medical Polymers Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Medical Polymers Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Medical Polymers Sales Value Share by Application (2021-2026) Table 43. Global Medical Polymers Sales Value Share by Application (2027-2032) Table 44. Global Medical Polymers Sales by Region: 2021 VS 2025 VS 2032 (kt) Table 45. Global Medical Polymers Sales by Region (2021-2026) & (kt) Table 46. Global Medical Polymers Sales Market Share by Region (2021-2026) Table 47. Global Medical Polymers Sales by Region (2027-2032) & (kt) Table 48. Global Medical Polymers Sales Market Share by Region (2027-2032) Table 49. Global Medical Polymers Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Medical Polymers Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Medical Polymers Sales Value Share by Region (2021-2026) Table 52. Global Medical Polymers Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Medical Polymers Sales Value Share by Region (2027-2032) Table 54. Global Medical Polymers Market Average Price (US$/t) by Region (2021-2026) Table 55. Global Medical Polymers Market Average Price (US$/t) by Region (2027-2032) Table 56. Global Medical Polymers Sales by Country: 2021 VS 2025 VS 2032 (kt) Table 57. Global Medical Polymers Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Medical Polymers Sales by Country (2021-2026) & (kt) Table 59. Global Medical Polymers Sales Market Share by Country (2021-2026) Table 60. Global Medical Polymers Sales by Country (2027-2032) & (kt) Table 61. Global Medical Polymers Sales Market Share by Country (2027-2032) Table 62. Global Medical Polymers Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Medical Polymers Sales Value Market Share by Country (2021-2026) Table 64. Global Medical Polymers Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Medical Polymers Sales Value Market Share by Country (2027-2032) Table 66. BASF SE Company Information Table 67. BASF SE Business Overview Table 68. BASF SE Medical Polymers Sales (kt), Value (US$ Million), Price (US$/t) and Gross Margin (2021-2026) Table 69. BASF SE Medical Polymers Product Portfolio Table 70. BASF SE Recent Development Table 71. Bayer Company Information Table 72. Bayer Business Overview Table 73. Bayer Medical Polymers Sales (kt), Value (US$ Million), Price (US$/t) and Gross Margin (2021-2026) Table 74. Bayer Medical Polymers Product Portfolio Table 75. Bayer Recent Development Table 76. Celanese Company Information Table 77. Celanese Business Overview Table 78. Celanese Medical Polymers Sales (kt), Value (US$ Million), Price (US$/t) and Gross Margin (2021-2026) Table 79. Celanese Medical Polymers Product Portfolio Table 80. Celanese Recent Development Table 81. DSM Company Information Table 82. DSM Business Overview Table 83. DSM Medical Polymers Sales (kt), Value (US$ Million), Price (US$/t) and Gross Margin (2021-2026) Table 84. DSM Medical Polymers Product Portfolio Table 85. DSM Recent Development Table 86. DuPont Company Information Table 87. DuPont Business Overview Table 88. DuPont Medical Polymers Sales (kt), Value (US$ Million), Price (US$/t) and Gross Margin (2021-2026) Table 89. DuPont Medical Polymers Product Portfolio Table 90. DuPont Recent Development Table 91. Solvay Company Information Table 92. Solvay Business Overview Table 93. Solvay Medical Polymers Sales (kt), Value (US$ Million), Price (US$/t) and Gross Margin (2021-2026) Table 94. Solvay Medical Polymers Product Portfolio Table 95. Solvay Recent Development Table 96. Eastman Chemical Company Information Table 97. Eastman Chemical Business Overview Table 98. Eastman Chemical Medical Polymers Sales (kt), Value (US$ Million), Price (US$/t) and Gross Margin (2021-2026) Table 99. Eastman Chemical Medical Polymers Product Portfolio Table 100. Eastman Chemical Recent Development Table 101. Evonik Company Information Table 102. Evonik Business Overview Table 103. Evonik Medical Polymers Sales (kt), Value (US$ Million), Price (US$/t) and Gross Margin (2021-2026) Table 104. Evonik Medical Polymers Product Portfolio Table 105. Evonik Recent Development Table 106. HEXPOL Company Information Table 107. HEXPOL Business Overview Table 108. HEXPOL Medical Polymers Sales (kt), Value (US$ Million), Price (US$/t) and Gross Margin (2021-2026) Table 109. HEXPOL Medical Polymers Product Portfolio Table 110. HEXPOL Recent Development Table 111. Exxon Mobil Company Information Table 112. Exxon Mobil Business Overview Table 113. Exxon Mobil Medical Polymers Sales (kt), Value (US$ Million), Price (US$/t) and Gross Margin (2021-2026) Table 114. Exxon Mobil Medical Polymers Product Portfolio Table 115. Exxon Mobil Recent Development Table 116. Formosa Plastics Company Information Table 117. Formosa Plastics Business Overview Table 118. Formosa Plastics Medical Polymers Sales (kt), Value (US$ Million), Price (US$/t) and Gross Margin (2021-2026) Table 119. Formosa Plastics Medical Polymers Product Portfolio Table 120. Formosa Plastics Recent Development Table 121. INEOS Company Information Table 122. INEOS Business Overview Table 123. INEOS Medical Polymers Sales (kt), Value (US$ Million), Price (US$/t) and Gross Margin (2021-2026) Table 124. INEOS Medical Polymers Product Portfolio Table 125. INEOS Recent Development Table 126. Victrex Company Information Table 127. Victrex Business Overview Table 128. Victrex Medical Polymers Sales (kt), Value (US$ Million), Price (US$/t) and Gross Margin (2021-2026) Table 129. Victrex Medical Polymers Product Portfolio Table 130. Victrex Recent Development Table 131. Colorite Compounds Company Information Table 132. Colorite Compounds Business Overview Table 133. Colorite Compounds Medical Polymers Sales (kt), Value (US$ Million), Price (US$/t) and Gross Margin (2021-2026) Table 134. Colorite Compounds Medical Polymers Product Portfolio Table 135. Colorite Compounds Recent Development Table 136. Raumedic Company Information Table 137. Raumedic Business Overview Table 138. Raumedic Medical Polymers Sales (kt), Value (US$ Million), Price (US$/t) and Gross Margin (2021-2026) Table 139. Raumedic Medical Polymers Product Portfolio Table 140. Raumedic Recent Development Table 141. Kraton Company Information Table 142. Kraton Business Overview Table 143. Kraton Medical Polymers Sales (kt), Value (US$ Million), Price (US$/t) and Gross Margin (2021-2026) Table 144. Kraton Medical Polymers Product Portfolio Table 145. Kraton Recent Development Table 146. Tianjin Plastics Company Information Table 147. Tianjin Plastics Business Overview Table 148. Tianjin Plastics Medical Polymers Sales (kt), Value (US$ Million), Price (US$/t) and Gross Margin (2021-2026) Table 149. Tianjin Plastics Medical Polymers Product Portfolio Table 150. Tianjin Plastics Recent Development Table 151. Shanghai New Shanghua Company Information Table 152. Shanghai New Shanghua Business Overview Table 153. Shanghai New Shanghua Medical Polymers Sales (kt), Value (US$ Million), Price (US$/t) and Gross Margin (2021-2026) Table 154. Shanghai New Shanghua Medical Polymers Product Portfolio Table 155. Shanghai New Shanghua Recent Development Table 156. Key Raw Materials Table 157. Raw Materials Key Suppliers Table 158. Medical Polymers Distributors List Table 159. Medical Polymers Customers List Table 160. Research Programs/Design for This Report Table 161. Authors List of This Report Table 162. Secondary Sources Table 163. Primary Sources List of Figures Figure 1. Medical Polymers Product Image Figure 2. Global Medical Polymers Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Medical Polymers Sales Value (2021-2032) & (US$ Million) Figure 4. Global Medical Polymers Sales (2021-2032) & (kt) Figure 5. Global Medical Polymers Sales Average Price (US$/t) & (2021-2032) Figure 6. Global Medical Polymers Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Medical Resins and Fibers Image Figure 10. Medical Elastomers Image Figure 11. Biodegradable Plastics Image Figure 12. Other Image Figure 13. Global Medical Polymers Sales Volume by Type (2021 VS 2025 VS 2032) & (kt) Figure 14. Global Medical Polymers Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Medical Polymers Sales Volume Share by Type (2021-2032) Figure 16. Global Medical Polymers Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Medical Polymers Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Medical Polymers Sales Value Share by Type (2021-2032) Figure 19. Medical Devices and Equipment Image Figure 20. Medical Packaging Image Figure 21. Others (Including Tissue Engineering and Cardio Stents) Image Figure 22. Global Medical Polymers Sales Volume by Application (2021 VS 2025 VS 2032) & (kt) Figure 23. Global Medical Polymers Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Medical Polymers Sales Volume Share by Application (2021-2032) Figure 25. Global Medical Polymers Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Medical Polymers Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Medical Polymers Sales Value Share by Application (2021-2032) Figure 28. Global Medical Polymers Sales by Region: 2021 VS 2025 VS 2032 (kt) Figure 29. Global Medical Polymers Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Medical Polymers Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Medical Polymers Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Medical Polymers Sales Value (2021-2032) & (US$ Million) Figure 33. North America Medical Polymers Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Medical Polymers Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Medical Polymers Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Medical Polymers Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Medical Polymers Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Medical Polymers Sales Value (2021-2032) & (US$ Million) Figure 39. South America Medical Polymers Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Medical Polymers Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Medical Polymers Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Medical Polymers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Medical Polymers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Medical Polymers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Medical Polymers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Medical Polymers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Medical Polymers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Medical Polymers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Medical Polymers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Medical Polymers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Medical Polymers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Medical Polymers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Medical Polymers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Medical Polymers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Medical Polymers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Medical Polymers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Medical Polymers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Medical Polymers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Medical Polymers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Medical Polymers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Medical Polymers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Medical Polymers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Medical Polymers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Medical Polymers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Medical Polymers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Medical Polymers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Medical Polymers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Medical Polymers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Medical Polymers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Medical Polymers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Medical Polymers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Medical Polymers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Medical Polymers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Medical Polymers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Medical Polymers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Medical Polymers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Medical Polymers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Medical Polymers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Medical Polymers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Medical Polymers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Medical Polymers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Medical Polymers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Medical Polymers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Medical Polymers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Medical Polymers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Medical Polymers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Medical Polymers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Medical Polymers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Medical Polymers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Medical Polymers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Medical Polymers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Medical Polymers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Medical Polymers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Medical Polymers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Medical Polymers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Medical Polymers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Medical Polymers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Medical Polymers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Medical Polymers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Medical Polymers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Medical Polymers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Medical Polymers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Medical Polymers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Medical Polymers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Medical Polymers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Medical Polymers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Medical Polymers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Medical Polymers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Medical Polymers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Medical Polymers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Medical Polymers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Medical Polymers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Medical Polymers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Medical Polymers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Medical Polymers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Medical Polymers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Medical Polymers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Medical Polymers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Medical Polymers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Medical Polymers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Medical Polymers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Medical Polymers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Medical Polymers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Medical Polymers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Medical Polymers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Medical Polymers Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Medical Polymers Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Medical Resins and Fibers
  • Medical Elastomers
  • Biodegradable Plastics
  • Other
Applications
  • Medical Devices and Equipment
  • Medical Packaging
  • Others (Including Tissue Engineering and Cardio Stents)
Companies covered
  • BASF SE
  • Bayer
  • Celanese
  • DSM
  • DuPont
  • Solvay
  • Eastman Chemical
  • Evonik
  • HEXPOL
  • Exxon Mobil
  • Formosa Plastics
  • INEOS
  • Victrex
  • Colorite Compounds
  • Raumedic
  • Kraton
  • Tianjin Plastics
  • Shanghai New Shanghua

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Medical Polymers Sales Value (2021-2032)
  4. 1.2.2 Global Medical Polymers Sales Volume (2021-2032)
  5. 1.2.3 Global Medical Polymers Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Medical Polymers Market Dynamics
  1. 2.1 Medical Polymers Industry Trends
  2. 2.2 Medical Polymers Industry Drivers
  3. 2.3 Medical Polymers Industry Opportunities and Challenges
  4. 2.4 Medical Polymers Industry Restraints
3 Medical Polymers Market by Company
  1. 3.1 Global Medical Polymers Company Revenue Ranking in 2025
  2. 3.2 Global Medical Polymers Revenue by Company (2021-2026)
  3. 3.3 Global Medical Polymers Sales Volume by Company (2021-2026)
  4. 3.4 Global Medical Polymers Average Price by Company (2021-2026)
  5. 3.5 Global Medical Polymers Company Ranking (2024-2026)
  6. 3.6 Global Medical Polymers Company Manufacturing Base and Headquarters
  7. 3.7 Global Medical Polymers Company Product Type and Application
  8. 3.8 Global Medical Polymers Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Medical Polymers Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Medical Polymers Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Medical Polymers Market by Type
  1. 4.1 Medical Polymers Type Introduction
  2. 4.1.1 Medical Resins and Fibers
  3. 4.1.2 Medical Elastomers
  4. 4.1.3 Biodegradable Plastics
  5. 4.1.4 Other
  6. 4.2 Global Medical Polymers Sales Volume by Type
  7. 4.2.1 Global Medical Polymers Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Medical Polymers Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Medical Polymers Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Medical Polymers Sales Value by Type
  11. 4.3.1 Global Medical Polymers Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Medical Polymers Sales Value by Type (2021-2032)
  13. 4.3.3 Global Medical Polymers Sales Value Share by Type (2021-2032)
5 Medical Polymers Market by Application
  1. 5.1 Medical Polymers Application Introduction
  2. 5.1.1 Medical Devices and Equipment
  3. 5.1.2 Medical Packaging
  4. 5.1.3 Others (Including Tissue Engineering and Cardio Stents)
  5. 5.2 Global Medical Polymers Sales Volume by Application
  6. 5.2.1 Global Medical Polymers Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Medical Polymers Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Medical Polymers Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Medical Polymers Sales Value by Application
  10. 5.3.1 Global Medical Polymers Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Medical Polymers Sales Value by Application (2021-2032)
  12. 5.3.3 Global Medical Polymers Sales Value Share by Application (2021-2032)
6 Medical Polymers Regional Sales and Value Analysis
  1. 6.1 Global Medical Polymers Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Medical Polymers Sales by Region (2021-2032)
  3. 6.2.1 Global Medical Polymers Sales by Region: 2021-2026
  4. 6.2.2 Global Medical Polymers Sales by Region (2027-2032)
  5. 6.3 Global Medical Polymers Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Medical Polymers Sales Value by Region (2021-2032)
  7. 6.4.1 Global Medical Polymers Sales Value by Region: 2021-2026
  8. 6.4.2 Global Medical Polymers Sales Value by Region (2027-2032)
  9. 6.5 Global Medical Polymers Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Medical Polymers Sales Value (2021-2032)
  12. 6.6.2 North America Medical Polymers Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Medical Polymers Sales Value (2021-2032)
  15. 6.7.2 Europe Medical Polymers Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Medical Polymers Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Medical Polymers Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Medical Polymers Sales Value (2021-2032)
  21. 6.9.2 South America Medical Polymers Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Medical Polymers Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Medical Polymers Sales Value Share by Country, 2025 VS 2032
7 Medical Polymers Country-level Sales and Value Analysis
  1. 7.1 Global Medical Polymers Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Medical Polymers Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Medical Polymers Sales by Country (2021-2032)
  4. 7.3.1 Global Medical Polymers Sales by Country (2021-2026)
  5. 7.3.2 Global Medical Polymers Sales by Country (2027-2032)
  6. 7.4 Global Medical Polymers Sales Value by Country (2021-2032)
  7. 7.4.1 Global Medical Polymers Sales Value by Country (2021-2026)
  8. 7.4.2 Global Medical Polymers Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Medical Polymers Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Medical Polymers Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Medical Polymers Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Medical Polymers Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Medical Polymers Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Medical Polymers Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Medical Polymers Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Medical Polymers Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Medical Polymers Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Medical Polymers Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Medical Polymers Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Medical Polymers Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Medical Polymers Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Medical Polymers Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Medical Polymers Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Medical Polymers Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Medical Polymers Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Medical Polymers Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Medical Polymers Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Medical Polymers Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Medical Polymers Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Medical Polymers Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Medical Polymers Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Medical Polymers Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Medical Polymers Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Medical Polymers Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Medical Polymers Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Medical Polymers Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Medical Polymers Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Medical Polymers Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Medical Polymers Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Medical Polymers Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Medical Polymers Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Medical Polymers Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Medical Polymers Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Medical Polymers Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Medical Polymers Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Medical Polymers Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Medical Polymers Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Medical Polymers Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Medical Polymers Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Medical Polymers Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Medical Polymers Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Medical Polymers Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Medical Polymers Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Medical Polymers Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Medical Polymers Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Medical Polymers Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Medical Polymers Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Medical Polymers Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Medical Polymers Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Medical Polymers Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Medical Polymers Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Medical Polymers Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Medical Polymers Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Medical Polymers Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Medical Polymers Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Medical Polymers Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Medical Polymers Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Medical Polymers Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Medical Polymers Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Medical Polymers Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Medical Polymers Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Medical Polymers Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Medical Polymers Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Medical Polymers Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Medical Polymers Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Medical Polymers Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Medical Polymers Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Medical Polymers Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Medical Polymers Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Medical Polymers Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Medical Polymers Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Medical Polymers Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Medical Polymers Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Medical Polymers Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Medical Polymers Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Medical Polymers Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Medical Polymers Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Medical Polymers Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Medical Polymers Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Medical Polymers Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Medical Polymers Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Medical Polymers Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 BASF SE
  2. 8.1.1 BASF SE Company Information
  3. 8.1.2 BASF SE Business Overview
  4. 8.1.3 BASF SE Medical Polymers Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 BASF SE Medical Polymers Product Portfolio
  6. 8.1.5 BASF SE Recent Developments
  7. 8.2 Bayer
  8. 8.2.1 Bayer Company Information
  9. 8.2.2 Bayer Business Overview
  10. 8.2.3 Bayer Medical Polymers Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Bayer Medical Polymers Product Portfolio
  12. 8.2.5 Bayer Recent Developments
  13. 8.3 Celanese
  14. 8.3.1 Celanese Company Information
  15. 8.3.2 Celanese Business Overview
  16. 8.3.3 Celanese Medical Polymers Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Celanese Medical Polymers Product Portfolio
  18. 8.3.5 Celanese Recent Developments
  19. 8.4 DSM
  20. 8.4.1 DSM Company Information
  21. 8.4.2 DSM Business Overview
  22. 8.4.3 DSM Medical Polymers Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 DSM Medical Polymers Product Portfolio
  24. 8.4.5 DSM Recent Developments
  25. 8.5 DuPont
  26. 8.5.1 DuPont Company Information
  27. 8.5.2 DuPont Business Overview
  28. 8.5.3 DuPont Medical Polymers Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 DuPont Medical Polymers Product Portfolio
  30. 8.5.5 DuPont Recent Developments
  31. 8.6 Solvay
  32. 8.6.1 Solvay Company Information
  33. 8.6.2 Solvay Business Overview
  34. 8.6.3 Solvay Medical Polymers Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Solvay Medical Polymers Product Portfolio
  36. 8.6.5 Solvay Recent Developments
  37. 8.7 Eastman Chemical
  38. 8.7.1 Eastman Chemical Company Information
  39. 8.7.2 Eastman Chemical Business Overview
  40. 8.7.3 Eastman Chemical Medical Polymers Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Eastman Chemical Medical Polymers Product Portfolio
  42. 8.7.5 Eastman Chemical Recent Developments
  43. 8.8 Evonik
  44. 8.8.1 Evonik Company Information
  45. 8.8.2 Evonik Business Overview
  46. 8.8.3 Evonik Medical Polymers Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Evonik Medical Polymers Product Portfolio
  48. 8.8.5 Evonik Recent Developments
  49. 8.9 HEXPOL
  50. 8.9.1 HEXPOL Company Information
  51. 8.9.2 HEXPOL Business Overview
  52. 8.9.3 HEXPOL Medical Polymers Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 HEXPOL Medical Polymers Product Portfolio
  54. 8.9.5 HEXPOL Recent Developments
  55. 8.10 Exxon Mobil
  56. 8.10.1 Exxon Mobil Company Information
  57. 8.10.2 Exxon Mobil Business Overview
  58. 8.10.3 Exxon Mobil Medical Polymers Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Exxon Mobil Medical Polymers Product Portfolio
  60. 8.10.5 Exxon Mobil Recent Developments
  61. 8.11 Formosa Plastics
  62. 8.11.1 Formosa Plastics Company Information
  63. 8.11.2 Formosa Plastics Business Overview
  64. 8.11.3 Formosa Plastics Medical Polymers Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Formosa Plastics Medical Polymers Product Portfolio
  66. 8.11.5 Formosa Plastics Recent Developments
  67. 8.12 INEOS
  68. 8.12.1 INEOS Company Information
  69. 8.12.2 INEOS Business Overview
  70. 8.12.3 INEOS Medical Polymers Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 INEOS Medical Polymers Product Portfolio
  72. 8.12.5 INEOS Recent Developments
  73. 8.13 Victrex
  74. 8.13.1 Victrex Company Information
  75. 8.13.2 Victrex Business Overview
  76. 8.13.3 Victrex Medical Polymers Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Victrex Medical Polymers Product Portfolio
  78. 8.13.5 Victrex Recent Developments
  79. 8.14 Colorite Compounds
  80. 8.14.1 Colorite Compounds Company Information
  81. 8.14.2 Colorite Compounds Business Overview
  82. 8.14.3 Colorite Compounds Medical Polymers Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Colorite Compounds Medical Polymers Product Portfolio
  84. 8.14.5 Colorite Compounds Recent Developments
  85. 8.15 Raumedic
  86. 8.15.1 Raumedic Company Information
  87. 8.15.2 Raumedic Business Overview
  88. 8.15.3 Raumedic Medical Polymers Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Raumedic Medical Polymers Product Portfolio
  90. 8.15.5 Raumedic Recent Developments
  91. 8.16 Kraton
  92. 8.16.1 Kraton Company Information
  93. 8.16.2 Kraton Business Overview
  94. 8.16.3 Kraton Medical Polymers Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Kraton Medical Polymers Product Portfolio
  96. 8.16.5 Kraton Recent Developments
  97. 8.17 Tianjin Plastics
  98. 8.17.1 Tianjin Plastics Company Information
  99. 8.17.2 Tianjin Plastics Business Overview
  100. 8.17.3 Tianjin Plastics Medical Polymers Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Tianjin Plastics Medical Polymers Product Portfolio
  102. 8.17.5 Tianjin Plastics Recent Developments
  103. 8.18 Shanghai New Shanghua
  104. 8.18.1 Shanghai New Shanghua Company Information
  105. 8.18.2 Shanghai New Shanghua Business Overview
  106. 8.18.3 Shanghai New Shanghua Medical Polymers Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Shanghai New Shanghua Medical Polymers Product Portfolio
  108. 8.18.5 Shanghai New Shanghua Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Medical Polymers Value Chain Analysis
  2. 9.1.1 Medical Polymers Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Medical Polymers Sales Mode & Process
  6. 9.2 Medical Polymers Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Medical Polymers Distributors
  9. 9.2.3 Medical Polymers Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst